Uncategorized

A scathing report from Wake Forest University accuses HCA of driving away doctors from Mission Hospital after the acquisition.

Even people with highly symptomatic long COVID may have “no clinically observable objective findings on routine laboratory testing,” according to a study published by the Annals of Internal Medicine.

Awards include funding for microscopy and imaging tools to help surgeons ensure all cancer is removed during a procedure.

A Boston Scientific spokesperson said the company still expects to close its $1.26 billion purchase of Silk Road Medical in the second half of the year.

Some industry watchers described the level of price discounts announced by Medicare as a “relief,” though they warned of bigger future implications for drug research.

Lykos will lay off approximately three-quarters of its staff amidst a reorganization aimed at helping the company complete a regulatory resubmission for its MDMA-assisted therapy.

The companies’ late-stage stumble could allow Moderna to widen its lead, with its mRNA-based combination vaccine eliciting superior immune responses against COVID-19 and three influenza strains.

For the Biden-Harris Administration to compare the newly announced negotiated Medicare prices to the list prices for these drugs is, at best, not very meaningful. At worst, it’s disingenuous.

Just months after a jury ordered payment to Pfizer in the patent infringement case, a Delaware judge has nullified the award and invalidated the patents behind the lawsuit involving AstraZeneca’s blockbuster lung cancer drug.

Imfinzi’s perioperative approval comes after both the FDA’s staffers and a panel of external experts expressed concerns about overtreatment when using the PD-L1 blocker both before and after surgery.